To reconstitute BPC-157 5mg, add 2 mL of bacteriostatic water, yielding a 2.5 mg/mL solution. For a standard 250 mcg dose, draw 0.1 mL (10 units on an insulin syringe). This guide walks Canadian researchers through the full reconstitution process, recommended dosages, and safe injection protocols for BPC-157.
What Is BPC-157 and Why Reconstitute It?
BPC-157 is a synthetic peptide derived from a protective protein found in the stomach. It is widely studied for its potential to accelerate healing in tendons, ligaments, muscles, and the gut. Researchers in Canada often purchase BPC-157 as a lyophilized powder in 5mg vials, which must be reconstituted before administration. Proper reconstitution ensures accurate dosing and preserves peptide stability. For those comparing healing peptides, our BPC-157 vs TB-500 comparison explains key differences.
Step-by-Step BPC-157 5mg Reconstitution Protocol
Reconstituting BPC-157 5mg is straightforward but requires sterile technique. Follow these steps precisely to avoid contamination and ensure accurate concentration.
Gather Your Supplies
- One vial of BPC-157 5mg lyophilized powder
- Bacteriostatic water (sterile water with 0.9% benzyl alcohol)
- Insulin syringe (1 mL with 29-31 gauge needle)
- Alcohol swabs
- Clean, flat work surface
Calculate the Diluent Volume
The amount of bacteriostatic water you add determines the final concentration. For a 5mg vial, adding 2 mL of bacteriostatic water gives a concentration of 2.5 mg/mL. This is the most common dilution because it makes dosing simple: every 0.1 mL (10 units) contains 250 mcg of BPC-157. Some researchers prefer 1 mL for a 5 mg/mL concentration, but the 2 mL dilution is easier to measure for typical research doses.
Reconstitution Procedure
- Wash your hands thoroughly and wipe the vial tops with an alcohol swab.
- Draw 2 mL of air into the syringe, then inject it into the bacteriostatic water vial to equalize pressure.
- Withdraw 2 mL of bacteriostatic water, keeping the needle tip below the fluid level.
- Slowly inject the water into the BPC-157 vial, aiming the stream at the glass wall (not directly onto the powder) to avoid foaming.
- Gently swirl the vial until the powder dissolves completely. Do not shake vigorously.
- Store the reconstituted peptide in the refrigerator at 2-8°C. It remains stable for up to 30 days.
BPC-157 Dosage Guide for Research
BPC-157 dosage varies based on the research goal. Most studies use a range of 200-500 mcg per day, often split into two injections. The table below shows common protocols using a 2.5 mg/mL solution.
| Dose (mcg) | Volume to Inject | Syringe Units |
|---|---|---|
| 200 mcg | 0.08 mL | 8 units |
| 250 mcg | 0.1 mL | 10 units |
| 300 mcg | 0.12 mL | 12 units |
| 500 mcg | 0.2 mL | 20 units |
Typical BPC-157 Cycles
A standard BPC-157 cycle lasts 4-6 weeks, followed by a 2-week break. For acute injuries, some researchers run a 2-4 week cycle. Chronic conditions may require longer cycles, but cycling off is recommended to prevent receptor desensitization. The daily dose is often split into morning and evening injections for sustained effects. For a detailed tendon recovery protocol, see our BPC-157 5mg dosage guide for tendon healing.
BPC-157 Injection Protocol
BPC-157 can be administered subcutaneously or intramuscularly. Subcutaneous injections are easier and less painful, while intramuscular injections may be preferred for localized muscle injuries. The peptide is systemic, so it works throughout the body regardless of injection site, but many researchers inject near the injury for potential local benefits.
Subcutaneous Injection Steps
- Choose an injection site with a layer of fat: abdomen (2 inches from navel), thigh, or upper arm.
- Clean the area with an alcohol swab and let it dry.
- Pinch a fold of skin and insert the needle at a 45-90 degree angle.
- Inject the solution slowly and steadily.
- Withdraw the needle and apply gentle pressure with a clean swab. Do not massage.
Intramuscular Injection Steps
- Select a muscle site: deltoid, thigh, or glute.
- Clean the site with alcohol.
- Insert the needle at a 90-degree angle into the muscle.
- Aspirate slightly to ensure no blood is drawn (if blood appears, withdraw and choose a new site).
- Inject slowly, then remove the needle and apply pressure.
Safety and Storage Tips for Canadian Researchers
Always use bacteriostatic water, not sterile water, to prevent bacterial growth. Reconstituted BPC-157 must be refrigerated and used within 30 days. Unreconstituted vials can be stored at room temperature away from light, or frozen for long-term storage. Never reuse needles or syringes. Dispose of sharps in a proper container. Canadian researchers should source peptides from reputable vendors that provide third-party testing. For pricing and availability in Quebec, check our BPC-157 5mg buying guide for Quebec.
Common Reconstitution Mistakes to Avoid
- Using the wrong diluent: Only bacteriostatic water is suitable. Sterile water lacks preservatives and can lead to contamination.
- Shaking the vial: Vigorous shaking can damage the peptide structure. Swirl gently.
- Incorrect volume calculation: Double-check your math. A 5mg vial with 2 mL diluent gives 2.5 mg/mL.
- Storing at room temperature: Reconstituted peptides degrade quickly if not refrigerated.
- Using a large-gauge needle: Insulin syringes (29-31 gauge) minimize tissue damage and pain.
Frequently Asked Questions
Can I reconstitute BPC-157 with saline?
No, saline (0.9% sodium chloride) lacks a preservative and can promote bacterial growth. Always use bacteriostatic water.
How long does reconstituted BPC-157 last?
When refrigerated, it remains stable for about 30 days. After that, potency may decline. Discard any unused solution after 30 days.
What is the best injection site for BPC-157?
Subcutaneous injection in the abdomen is the most common. For localized injuries, some researchers inject near the site, but systemic effects are well-documented.
Can I mix BPC-157 with other peptides in the same syringe?
It is not recommended due to potential interactions or degradation. Use separate syringes and injection sites. For combined protocols, see our BPC-157 TB-500 blend dosage guide.
Final Thoughts on BPC-157 Reconstitution and Use
Proper reconstitution is the foundation of effective BPC-157 research. By following this guide, Canadian researchers can ensure accurate dosing, maintain peptide stability, and minimize risks. Always prioritize sterile technique, correct dilution, and safe injection practices. With a clear protocol in place, BPC-157 can be a valuable tool in healing and recovery studies.